My Tiny Feed

elmundo.es

Diabetic Macular Edema: Causes, Diagnosis, and AI-Driven Treatment

Diabetic macular edema (DME) is a vision-threatening complication of diabetes. This article explains its causes, diagnosis, and treatment advancements using AI.

Read original article in Spanish

Spanish

Spain

HealthArtificial IntelligenceDiabetesMedical TechnologyVisionEye Health

Federación Española De Diabetes (Fede)Instituto Oftalmológico Fernández-Vega

Antonio LavadoMaribel López Gálvez

Explain the mechanism by which DME develops in the eye.: DME occurs due to high blood glucose levels damaging blood vessels in the eye, leading to fluid leakage and swelling in the macula, the part of the retina responsible for sharp vision.
What diagnostic tool is used to assess DME, and what are its benefits?: Optical coherence tomography (OCT) is a valuable diagnostic tool for DME, providing detailed images of the retina to assess the severity and guide treatment.
How are advancements in AI impacting the diagnosis and treatment of DME?: Recent advancements in artificial intelligence are enhancing the interpretation of OCT images, improving diagnostic accuracy and treatment selection, ultimately improving the quality of life for DME patients.
What is diabetic macular edema (DME) and how prevalent is it among diabetic individuals?: Diabetic macular edema (DME) is a complication of diabetes that causes blurry vision and affects 2-10% of diabetic patients, primarily those with type 2 diabetes.
Why is early diagnosis of DME important, and what is the role of regular eye examinations?: Early diagnosis is crucial because DME is initially asymptomatic, but early detection can help prevent vision loss. Regular eye exams are essential for those with diabetes.

Jan 21, 10:09

AI Tool Detects Early Dementia Signs from Retinal Scans

Scottish researchers developed an AI tool using almost a million eye scans to detect early dementia signs from retinal photographs, aiming for wider rollout to opticians by 2026, improving early diagnosis and patient outcomes.

Jan 5, 13:06

AI in Australian Fertility Clinics Raises Ethical Concerns

AI is being used in Australian fertility clinics to select embryos, raising ethical concerns about transparency, informed consent, and potential bias; the $1.49 billion fertility industry's growth highlights the need for regulation.

Jan 4, 07:10

Shanghai Establishes First Medical AI Application Testing Center

Shanghai launched its first medical AI application testing and verification center on Friday, with twelve leading institutions participating to validate AI models for disease prediction, diagnostics, treatment, and drug discovery, addressing accuracy and ethical concerns.

Dec 30, 19:07

AI-Driven Cancer Treatment in North Rhine-Westphalia Receives €20 Million Funding

In North Rhine-Westphalia, Germany, approximately 100,000 people are diagnosed with cancer yearly; Minister-President Hendrik Wüst visited the West German Proton Therapy Center (WPE) in Essen, which uses AI and proton therapy to improve diagnosis and treatment, receiving €20 million in state funding and additional federal support as a nationally recognized center.